Skip to main content
. Author manuscript; available in PMC: 2020 Dec 24.
Published in final edited form as: JAMA. 2016 Apr 26;315(16):1767–1777. doi: 10.1001/jama.2016.2884

Table 1.

Diagnosis of Lyme Disease, Human Granulocytic Anaplasmosis and Babesiosis

Disease Manifestation Diagnostic Approach Additional Considerations
Lyme disease Erythema migrans Visual inspection of skin lesion9 Serology not recommended because seropositivity <40% on acute phase serum sample8.
Extracutaneous manifestations including but not limited to: facial nerve palsy, meningitis, radiculopathy, myopericarditis, arthritis Serologic testing132: EIA followed by western blot (IgM and IgG western blots if ≤4 weeks of symptoms; IgG western blot only if >4 weeks or for Lyme arthritis)a In Lyme meningitis, consider testing CSF for intrathecal borrelial antibody production and for borrelial DNA5; in Lyme arthritis, consider testing synovial fluid for borrelial DNA43.
HGA Fever, typically with leukopenia, thrombocytopenia, and/or increased transaminases Blood smear87;
buffy coat smear;
PCR for A. phagocytophilum
DNA.
Serology not routinely recommended except for retrospective diagnosis in treated patients. Seropositivity < 50% on acute phase serum sample and seropositivity alone does not establish the presence of active infection55.

Failure to defervesce within 48 hours of initiation of doxycycline is evidence against the diagnosis2.
Babesiosis Fever, typically with anemia, thrombocytopenia, elevated lactate dehydrogenase, hyperbilirubinemia and/or increased transaminases Blood smear preferred56;
PCR for B. microti DNA is an alternative.
Serologic testing for IgM/IgG antibodies by indirect immunofluorescent assay can be performed, but seropositivity per se does not indicate active infection56.
a

see text for potential alternative testing strategies under consideration